Status of a Real-Life Cohort of Patients with Moderate-to-severe Plaque Psoriasis Treated with Secukinumab and Considerations on the Use of Biological Agents in the Covid-19 Era
EXPERT OPINION ON BIOLOGICAL THERAPY(2020)
Key words
Anti-IL-17,coronavirus,Covid-19,psoriasis,secukinumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined